US regulators may consider intervening in pharma company mergers and acquisitions if they feel that they could create drug shortages.
In a Federal Register notice announcing a Nov. 27 public meeting on shortage prevention and mitigation, FDA's inter-agency drug shortage task force listed "heighten scrutiny of proposed mergers and...